 | |
| Clinical data | |
|---|---|
| Other names | DOEF; 2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine; 4-(2-Fluoroethyl)-2,5-dimethoxyamphetamine |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic;Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | 1–2 hours[1] Peak: 3 hours[1] |
| Duration of action | 12–16 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C13H20FNO2 |
| Molar mass | 241.306 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine (DOEF) is apsychedelic drug pf thephenethylamine,amphetamine, andDOx families.[1][2][3] In his bookPiHKAL (Phenethylamines I Have Known and Loved),Alexander Shulgin lists DOEF's dose as 2 to 3.5 mgorally and itsduration as 12 to 16 hours.[1] The drug'sonset was 1 to 2 hours and peak effects occurred after 3 hours.[1] The effects of DOEF were reported to includeunworldliness,closed-eyeimagery no appreciableopen-eyevisuals or not highly visual,time dilation,music anderotic enhancement, nobody discomfort,insomnia, andsleep disruption, among others.[1] DOEF was first described in thescientific literature byAlexander Shulgin and colleagues in 1988.[4] Subsequently, it was described in greater detail by Shulgin inPiHKAL in 1991.[1] The drug is acontrolled substance inCanada under phenethylamine blanket-ban language.[5]
 | Thishallucinogen-related article is astub. You can help Wikipedia byadding missing information. |
